CHU PHARMA Makes Appearance at API China 2026 in Wuhan Wuhan, Nov 11, 2026 — The 95th API China kicks off at Wuhan International Expo Center. CHU PHARMA showcases its portfolio of high-quality APIs and pharmaceutical intermediates, bringing integrated global pharmaceutical export solutions to worldwide buyers. CHU PHARMA presents Tirzepatide, Ogliprazide, Nicardipine, Semaglutide and other key API products compliant with GMP, USP and BP standards. The team engages with global partners, discussing market access, regulatory support and stable supply for Africa and Southeast Asia markets. Leo Dong, Overseas Sales Director of CHU PHARMA, states that CHU PHARMA will keep expanding emerging markets and deliver reliable API supply & regulatory services for global pharmaceutical clients.